RHY 3.13% 6.2¢ rhythm biosciences limited

Ann: MST Access Financial Diagnostics Presentation, page-48

  1. 561 Posts.
    lightbulb Created with Sketch. 86
    DNA based kits seem to be more expensive by an order of magnitude. They’re slightly more accurate - but also longer to process.

    The other major factor in the mix is integration. Colostat will fit into existing pathology architecture tomorrow. Other systems not so much - requiring bespoke processing hardware to be bought and taught to staff.
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
(20min delay)
Last
6.2¢
Change
-0.002(3.13%)
Mkt cap ! $15.41M
Open High Low Value Volume
6.9¢ 6.9¢ 6.2¢ $9.837K 157.8K

Buyers (Bids)

No. Vol. Price($)
1 49398 6.2¢
 

Sellers (Offers)

Price($) Vol. No.
6.5¢ 29999 1
View Market Depth
Last trade - 13.01pm 26/08/2024 (20 minute delay) ?
RHY (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.